Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation  by Caillon, Lucie et al.
Biochimica et Biophysica Acta 1828 (2013) 2091–2098
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemEvaluation of membrane models and their composition for islet amyloid
polypeptide-membrane aggregationLucie Caillon, Olivier Lequin, Lucie Khemtémourian ⁎
UPMC Univ Paris 06, UMR 7203 CNRS-UPMC-ENS, Laboratoire des Biomolécules, 4 place Jussieu, 75005 Paris, FranceAbbreviations: CD, circular dichroism; DMSO, dimeth
Amyloid Polypeptide; HFIP, 1,1,1,3,3,3-hexaﬂuoro-2-pro
vesicle; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocho
glycero-3-phospho-L-serine; DOPG, 1,2-dioleoyl-sn
glycerol); DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethano
sn-glycero-3-phosphocholine; DHPC, 1,2-dihexanoyl-sn-gl
1,2-dipalmitoyl-sn-glycero-3-phosphocholine; POPC, 1-p
phosphocholine; Chol, cholesterol; SM, sphingomyelin; S
DPC, dodecyl phosphocholine; ThT, Thioﬂavin T
⁎ Corresponding author. Tel.: +33 1 44 27 31 15; fax
E-mail address: lucie.khemtemourian@upmc.fr (L. K
0005-2736/$ – see front matter © 2013 Elsevier B.V. All
http://dx.doi.org/10.1016/j.bbamem.2013.05.014a b s t r a c ta r t i c l e i n f oArticle history:
Received 31 October 2012
Received in revised form 26 April 2013
Accepted 13 May 2013
Available online 23 May 2013
Keywords:
Amyloid
IAPP
Model membranes (LUV SUV, bicelles,
micelles)
Phospholipid
Aggregation kinetics
Fibril morphologyHuman islet amyloid polypeptide (IAPP) forms amyloid ﬁbrils in the pancreatic islets of patients suffering
from type 2 diabetes mellitus (T2DM). The formation of IAPP ﬁbrils has been shown to cause membrane dam-
age which most likely is responsible for the death of pancreatic islet β-cells during the pathogenesis of T2DM.
Several studies have demonstrated a clear interaction between IAPP and lipid membranes. However the ef-
fect of different lipid compositions and of various membrane mimetics (including micelles, bicelles, SUV
and LUV) on ﬁbril formation kinetics and ﬁbril morphology has not yet systematically been analysed. Here
we report that the interaction of IAPP with various membrane models promoted different processes of ﬁbril
formation. Our data reveal that in SDS and DPC micelles, IAPP adopts a stable α-helical structure for several
days, suggesting that the micelle models may stabilize monomeric or small oligomeric species of IAPP. In con-
trast, zwitterionic DMPC/DHPC bicelles and DOPC SUV accelerate the ﬁbril formation compared to zwitter-
ionic DOPC LUV, indicating that the size of the membrane model and its curvature inﬂuence the ﬁbrillation
process. Negatively charged membranes decrease the lag-time of the ﬁbril formation kinetics while phospha-
tidylethanolamine and cholesterol have an opposite effect, probably due to the modulation of the physical
properties of the membrane and/or due to direct interactions with IAPP within the membrane core. Finally,
our results show that the modulation of lipid composition inﬂuences not only the growth of ﬁbrils at the
membrane surface but also the interactions of β-sheet oligomers with membranes.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Islet amyloid polypeptide (IAPP) is a 37-residue peptide hormone
produced, stored and secreted together with insulin by the pancreatic
β-cells. IAPP plays, in its soluble monomeric form, a role in the regula-
tion of glucose homeostasis, in gastric emptying and in other cellular
processes [1–4]. Human IAPP has a strong amyloidogenic propensity
that has been linked to β-cell death in type 2 diabetes mellitus
(T2DM) [5]. The amyloid deposits also named amyloid ﬁbrils are com-
posed of β-sheet aggregates with a characteristic structure similar to
those found in Alzheimer's disease, Parkinson's disease, spongiform en-
cephalopathy and a variety of other degenerative diseases [6–8].yl sulfoxide; IAPP, human Islet
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hemtémourian).
rights reserved.It has been suggested that IAPP impairs the membranes of β-cells,
leading to β-cell dysfunction and the development of T2DM [9,10]. It
was proposed that this membrane disruption can be due to the grow-
ing IAPP ﬁbrils [11] or to toxic oligomers [10,12,13]. Several studies
have demonstrated a clear interaction between amyloid peptides
and lipid membrane and have shown that membrane can modify
the peptide structure and/or the kinetics of ﬁbril formation
[10,13–17]. It is noteworthy that the lipid systems used were often
very simplistic models such as DPC micelles, SDS micelles, and vesi-
cles containing phosphatidylcholine or a mixture of phosphatidylcho-
line and negatively charged lipids. In addition, comparison of
published results is often hampered by the use of different systems
and lipid compositions in various studies. Thus, it appears crucial to
provide a critical assessment of the different membrane models
used in the literature and to examine a larger number of membrane
compositions to determine how a speciﬁc lipid composition or a spe-
ciﬁc membrane model could induce variation in the aggregation ki-
netics and ﬁbril formation.
There is little information on the lipid compositions in pancreatic
islets, but it was shown that phosphatidylcholine (PC) was the most
abundant phospholipid class, followed by phosphatidylethanolamine
(PE), sphingomyelin (SM) and phosphatidylserine (PS) [18,19]. In ad-
dition, it was shown that negatively charged membranes promote
IAPP aggregation in vitro while the presence of cholesterol seems to
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ponents (PC, PE, PS, SM and Chol) as well as phosphatidylglycerol
(PG) into our model lipid system in proportions that represent a con-
sensus between previous studies and data in literature.
To gain further insight into the potential importance of lipid com-
position we performed a biophysical study of IAPP in lipid bilayers of
different compositions and in various membrane models (including
micelles, bicelles, SUV and LUV). In particular, we examined the struc-
ture, the aggregation behaviour and the ﬁbril morphology of IAPP.
The vesicles made from the predominant plasma membrane phos-
pholipid (phosphatidylcholine) were used as our core model mem-
brane to which other lipids were added. In total, the aggregation of
IAPP was studied in 16 membrane models of different compositions.
The different lipid systems used to induce IAPP aggregation showed
different kinetic parameters and most of them except the micelles
showed ﬁne ﬁbril structures all consistent with β-sheet aggregates.
2. Materials and methods
2.1. Materials
The synthesis of human IAPP with an amidated C-terminus and di-
sulﬁde bridge was performed using Fmoc chemistry at the Institut de
Biologie Intégrative (IFR83-Université Pierre et Marie Curie). The
peptide was puriﬁed by reverse phase high-performance liquid
chromatography (HPLC). Purity of peptide was higher than 95% as
determined by analytical HPLC and peptide identity was conﬁrmed
by MALDI-TOF mass spectrometry. Its amino acid sequence
is: KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY. DOPC, POPC,
DMPC, DOPE and cholesterol (obtained from Genzyme, Switzerland)
and DPC, DOPS, DOPG, DPPC and SM (obtained from Avanti Polar
Lipids, Alabaster, USA) were used without further puriﬁcation. SDS
and Thioﬂavin T (ThT) were obtained from Sigma.
2.2. Preparation of peptide samples
An essential criterion for measuring aggregation kinetics of amyloid
peptides and thus the effect of phospholipids is to start with a mono-
meric form of the peptide. Therefore, peptide stock solutions were
freshly prepared prior to all experiments using the same batch. Peptide
was dissolved at a concentration of 1 mM in hexaﬂuoro-isopropanol
(HFIP) and incubated for at least 1 h. Next, HFIP was evaporated,
followed by vacuum desiccation for at least 1 h. For the ThT ﬂuores-
cence and the microscopy experiments, the peptide ﬁlm was then
dissolved in DMSO to a ﬁnal peptide concentration of 0.2 mM. For
those experiments, we used the same concentration of DMSO (5% in
the ﬁnal volume) and hence we were able to compare the shape of
the curve and the lag-time. For the CD experiments, the resulting pep-
tide ﬁlm was solubilized by addition of a dispersion of LUV, bicelles or
micelles in 10 mM sodium phosphate buffer, pH 7.4.
2.3. Preparation of large unilamellar vesicles (LUV)
Each lipid system was prepared by dissolving the desired lipids in
chloroform or chloroform/methanol (3:1) in a glass tube. The solvent
was evaporated with dry nitrogen gas yielding a lipid ﬁlm that was
subsequently kept in a vacuum desiccator for 30 min. Lipid ﬁlms
were hydrated for at least 30 min in 10 mM Tris/HCl, 100 mM NaCl,
pH 7.4 for the ﬂuorescence and microscopy experiments and in
10 mM sodium phosphate buffer, pH 7.4 for the CD experiments.
The lipid suspensions were subjected to 10 freeze–thaw cycles, at
temperatures of approximately −190 °C and 50 °C, respectively,
and subsequently extruded 19 times through a mini-extruder (Avanti
Alabaster, AL) equipped with polycarbonate membranes (at 50, 200
and 800 nm cut-off). The phospholipid content of lipid stocksolutions and vesicle preparations was determined by assessing inor-
ganic phosphate according to Rouser [21].
2.4. Preparation of SDS and DPC micelles and DMPC/DHPC bicelles
Micelles of SDS and DPC were obtained by dissolving SDS or DPC
in appropriate buffer to a ﬁnal concentration of 10 mM (above the
cmc). Bicelles were prepared according to Raffard et al. [22] by hy-
drating DMPC and DHPC with appropriate buffer to a ﬁnal concentra-
tion of 10 mM DHPC and 5 mM DMPC. The mixture was then
submitted three times to the following cycle: 5 min of centrifugation
at 4000 rpm, vigorous vortexing, freezing in liquid nitrogen, heating
in a 50 °C water bath, vigorous vortexing.
2.5. CD spectroscopy
CD spectra were measured on a Jasco 815 spectropolarimeter
(Jasco Inc., Easton, MD) over the wavelength range 190–260 nm, by
using 0.1 cm path length quartz cell (internal volume 200 μL) from
Hellma GmbH. CD spectra were recorded at 25 °C, at 0.2 nm intervals
and 10 nm·min−1 scan speed. Measurements were carried out in
10 mM phosphate buffer at pH 7.4. Peptide concentrations were
25 μM in the presence of lipids (peptide:lipid ratio 1:20) or in the
presence of detergents (10 mM SDS or DPC). To follow IAPP confor-
mational changes, spectra were recorded at regular intervals and
the CD signal at 220 nm was plotted vs. time of incubation. Experi-
mental values were ﬁtted to a Boltzmann sigmoidal equation:
θ220 ¼
θi−θf
1þ e t−t0:5ð Þ=dt þ θf :
In this equation, θi and θf are the initial and ﬁnal ellipticity values
at 220 nm, t0.5 is the time to 50% of transition conformational and dt a
time constant. The CD experiments were performed 2 times on differ-
ent days using different IAPP stock solutions and different vesicles.
2.6. Thioﬂavin T assays
The kinetics of ﬁbril formation were measured using the ﬂuores-
cence intensity increase upon binding of the ﬂuorescent dye
Thioﬂavin T (ThT) to ﬁbrils. A plate reader (Fluostar Optima, Bmg
Labtech) and standard 96-well ﬂat-bottom black microtiter plates in
combination with a 440 nm excitation ﬁlter and a 485 nm emission
ﬁlter were used. The ThT assay was started by adding 10 μL of a
0.2 mM IAPP solution in DMSO to 190 μL of a mixture of 10 μM ThT,
LUV (peptide concentration: 10 μM peptide; 200 μM lipid; 10 mM
detergent) and 10 mM Tris/HCl, 100 mM NaCl, pH 7.4. The microtiter
plate was shaken for 10 s directly after addition of all components,
but not during the measurement. The ThT assay was performed 3
times, each in triplicate, on different days, using different IAPP stock
solutions. The replicates of each system showed fairly consistent
reproducibility.
2.7. Electron microscopy
Peptide and vesicles were incubated under the same conditions as
in the Thioﬂavin T assay. Aliquots (25 μL) of this mixture were
adsorbed onto glow-discharged carbon-coated 300-mesh copper
grids for 2 min. Grids were then blotted and dried. Grids were nega-
tively stained for 45 s on 2% uranyl acetate, blotted and dried. Grids
were examined using a ZEISS 912 Omega electron microscope operat-
ing at 80 kV. The samples were prepared and observed 2 times using
different IAPP and vesicles stocks.
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3.1. Preparation of IAPP and membrane models
To evaluate the role of the lipid composition as well as the mem-
brane models on IAPP aggregation, we performed a systematic
study using circular dichroism, ﬂuorescence and microscopy. An es-
sential criterion for measuring and comparing aggregation kinetics
of IAPP on the different membrane models is to start with a mono-
meric form of the peptide. Indeed, amyloid peptides are known to
produce variable results due to preformed oligomers acting as
seeds. Therefore, the IAPP peptide stocks were always made fresh
and preincubated in HFIP, a treatment that was shown to lead to mo-
nomeric species essentially [23]. The experiments were performed in
triplicate and 16 membrane models were tested for this study includ-
ing detergent micelles, bicelles, small unilamellar vesicles (SUV) and
large unilamellar vesicles (LUV). Detergent micelles commonly con-
sist of amphiphiles such as dodecylphosphocholine (DPC) or sodium
dodecyl sulphate (SDS). The detergent head groups may be designed
to physically mimic the surface of a biological membrane. However, a
micelle typically contains 50–80 detergent molecules; serious con-
cerns arise regarding the very small radius of curvature and the lack
of a true lipid bilayer. Consequently, the study was also performed
using bicelles, which are formed by mixing long-chain and short-
chain phospholipids [24]. The bicelle interior consists of a true lipid
bilayer, while the short-chain phospholipid is believed to be seques-
tered to the rim of the disks. Under our conditions of temperature,
hydration, and lipid ratios, the mixtures were reported to form fast-
tumbling bicelles also named isotropic bicelles. Finally, LUV from
diverse compositions and SUV were used to examine the role of the
phospholipids and of the liposome size in IAPP ﬁbril formation.Fig. 1. CD spectra (190–260 nm) of IAPP (20 μM) freshly dissolved (black) and after 24 h o
(7:3) LUV. (D) CD kinetic study in DMPC LUVs. Overlaid CD spectra recorded at 30 min inter
recorded after 6 h30. (E) Time course of CD ellipticity at 220 nm.3.2. IAPP undergoes a conformational rearrangement depending on the
membrane composition
We previously showed that the conformation of IAPP in solution
and in the presence of membranes changes within a few hours from
random coil/α-helical conformation to β-sheet structure, indicative
of amyloid ﬁbrils [25]. The conformational studies on IAPP on differ-
ent membrane models were conducted by recording CD spectra in
the range 190–260 nm at 30 min intervals in phosphate buffer with-
out sodium chloride so as to increase the signal-to-noise ratio, keep-
ing in mind that the absence of salt may slow down the β-sheet
transition [26]. In the presence of SDS micelles (Fig. 1A), the spectrum
of IAPP displays negative ellipticity at 208 and 222 nm, characteristic
of an α-helical backbone structure. After a few days of incubation,
IAPP retains its α-helical conformation and shows no evidence of
β-sheet structure that would indicate ﬁbril formation. Similar results
were observed with DPC micelles (data not shown). Surprisingly, in
the presence of DMPC/DHPC zwitterionic bicelles (Fig. 1B), IAPP
adopts initially an α-helical structure but converts rapidly in around
2–3 h to β-sheet structure, suggesting the formation of ﬁbrils.
It was already shown that upon interaction with membranes
containing negatively charged lipids, IAPP adopts an α-helical confor-
mation, which in time undergoes a transition to β-sheet. The spec-
trum of IAPP in DOPC/DOPS (7:3) LUV in Fig. 1C conﬁrms this
behaviour. The α-helical to β-sheet transition occurs after 30 min.
Similar results were observed in DOPC/DOPG (7:3) LUV with a transi-
tion time of approximately 60 min (data not shown).
In all other CD spectra, IAPP freshly added to the membrane models
displayed typical random coil conformation with minima at 200 nm
corresponding to the non-amyloidogenic conformation of monomeric
or small soluble IAPP. After a few hours of incubation, the CD spectraf incubation (grey) in (A) SDS micelles, (B) DHPC/DMPC bicelles, and (C) DOPC/DOPS
vals. Plot color code: black: CD spectrum recorded after 5 min, light grey: CD spectrum
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mum around 220 nm, characteristic of the amyloidogenic conforma-
tion. In Fig. 1D the overlaid CD spectra of IAPP in DMPC LUV show the
conformation transition from the random coil to the β-sheet structure.
The prevalence of β-sheet secondary structure after 3 h is clearly indi-
cated by the appearance of a negative band at 220 nm and the loss of
the negative band at 200 nm. By plotting the CD value at 220 nm
against time, a sigmoid curve, in agreement with previous reports
[27,28], is obtained and is characterized by three steps: a lag phase, an
exponential growth phase and a plateau (Fig. 1E). During the ﬁrst
step, IAPP retains its random coil conformation, then an exponential in-
crease in β-sheet content is observed and ﬁnally the plateau deﬁned the
beginning of ﬁbril formation. Extended incubation time caused the CD
signal to decrease proving that IAPP was becoming insoluble. The time
required to reach half-value of the maximum CD signal at 220 nm
(t0.5), reported in Table 1, is used to compare the lag time of the sigmoi-
dal transitions of the kinetic curves of CD experiments in different
membrane models. Depending on the membrane models, the random
coil to β-sheet transition occurs between 2 to 16 h (Table 1). As a refer-
ence, the lipid-free system presented a transition time of 9.7 ± 0.1 h
and an elongation rate of 1.3 ± 0.1 h−1. DMPC LUV provided the
shortest random coil to β-sheet transition time (2.4 ± 0.1 h) but the
slowest elongation rate (0.3 ± 0.1 h−1). In contrast, DPPC LUV
presented the longest conformational transition time (15.6 ± 0.4 h)
with slightly slower elongation rate (0.6 ± 0.3 h−1) than DOPC LUV
(0.9 ± 0.1 h−1). The vesicles containing cholesterol (DOPC/Chol,
DOPC/Chol/SM and POPC/Chol/SM) produced an increase in conforma-
tional transition time and a decrease in elongation rate while adding
30% of sphingomyelin without cholesterol slightly reduced the transi-
tion time to 8.6 ± 0.1 h and promoted a slower elongation rate
(0.5 ± 0.1 h−1). Larger size DOPC vesicles (800 nm) induced no
change in the transition time, neither in the elongation rate compared
to 200 nmDOPC. However, 50 nmDOPC SUVandDOPC/DOPE LUVpro-
vided a short transition time (7.4 ± 0.1 h and 7.8 ± 0.1 h respectively)
and a slow elongation rate (0.6 ± 0.1 h−1and 0.4 ± 0.1 h−1). Overall,
our CD data show that the transition from α-helical to β-sheet or from
random coil to β-sheet is observed in all system but micelles. In these
latter models, the α-helical structure is stable for several days,
suggesting the absence of ﬁbril formation.
3.3. Effects of membrane composition and membrane size on IAPP ﬁbril
formation
To examine whether indeed IAPP amyloid ﬁbrils are formed in all
systems but micelles, we used the complementary approach of mea-
suring ﬂuorescence intensity changes upon binding the amyloid spe-
ciﬁc dye Thioﬂavin T (ThT), which is a commonly used method to
detect amyloid ﬁbrils [29]. Fig. 2 shows typical S-shaped curves char-
acteristic of amyloid ﬁbril formation [23], obtained for IAPP inTable 1
Kinetic parameters (lag time t0.5 and elongation rate dt) of IAPP β-sheet formation in
the different media determined using the time course of absolute CD ellipticity at
220 nm.
Membranes t0.5 (h) dt (h−1)
Lipid-free 9.7 ± 0.1 1.3 ± 0.1
DOPC 8.9 ± 0.1 0.9 ± 0.1
DOPC/DOPE (7:3) 7.8 ± 0.1 0.4 ± 0.1
DOPC 50 nm 7.4 ± 0.1 0.6 ± 0.1
DOPC 800 nm 8.5 ± 0.1 0.8 ± 0.1
DMPC 2.4 ± 0.1 0.3 ± 0.1
DPPC 15.6 ± 0.4 0.6 ± 0.3
POPC 6.1 ± 0.3 0.7 ± 0.3
DOPC/SM (7:3) 8.6 ± 0.1 0.5 ± 0.1
DOPC/Chol (7:3) 10.0 ± 0.2 0.4 ± 0.2
DOPC/Chol/SM (4:3:3) 11.9 ± 1.0 0.7 ± 0.6
POPC/Chol/SM (1:1:1) 14.4 ± 0.3 1.0 ± 0.2different membrane models, except the micelles (Fig. 2B open square
and cross). Table 2 represents the time required to reach half-value of
the maximum ThT signal (t0.5), and is used to compare the lag time of
the sigmoidal transitions in the kinetic curves of ThT-ﬂuorescence
experiments in different membrane models. Depending on the mem-
brane models, the monomer/small soluble oligomers to ﬁbril forma-
tion transition occurs between 2 to 20 h (Table 2). The lipid-free
system showed a transition time of 9.7 ± 1.0 h and an elongation
rate of 1.5 ± 0.2 h−1. In DOPC/DOPS (7:3) and DOPC/DOPG (7:3),
the lag time is approximately 2 h while in DOPC only and in DOPC/
DOPE the lag time reaches 12 h and 21 h, respectively (Fig. 2A).
These results indicate that the presence of negatively charged lipids
largely accelerates the ﬁbril formation while the presence of the zwit-
terionic phosphatidylethanolamine slows down the ﬁbril formation.
Next, the role of the membrane models and vesicles size was exam-
ined using SDS and DPC micelles, DMPC/DHPC bicelles, 50 nm SUV
and 800 nm LUV. As shown in Fig. 2B, analysis of the kinetics of ﬁbril
formation in the presence of DMPC/DHPC bicelles, SUV and LUV
yields the typical S-shaped curve for IAPP. In addition, the lag time
is shorter in bicelles and SUV (~7–9 h) than that in 800 nm LUV
(~16 h), suggesting that IAPP-ﬁbril formation might be favoured by
small membrane with high curvature. In contrast, the data do not
show any increase in time in ﬂuorescence for IAPP in DPC and in
SDS micelles, supporting the notion that in these media IAPP is not
ﬁbrillogenic under the same experimental conditions. These results
suggest that the micelles stabilize a monomeric form of IAPP and
that the size of the membrane mimetics and their curvature inﬂuence
the ﬁbrillation process. Then, the role of the length of the lipid chains
as well as the degree of unsaturation was examined using DMPC,
DPPC and POPC LUV. Our results show a quite similar proﬁle of kinet-
ics of IAPP-ﬁbril formation in these vesicles with a lag-time of 11–
15 h (Fig. 2C) suggesting that the lipid chains have a slight effect on
ﬁbril formation. Finally, the kinetics of IAPP ﬁbril formation was stud-
ied in the presence of cholesterol and sphingomyelin (Fig. 2D). These
two lipids are components of lipid microdomains, also called lipid
rafts, and are considered to be a platform of a large number of events
in plasma membrane [30–32]. Thus, we performed ThT-ﬂuorescence
experiments using the following vesicles: DOPC/Chol (7:3), DOPC/
SM (7:3), DOPC/Chol/SM 4:3:3 and POPC/Chol/SM 1:1:1. Our results
show that ﬁbrils are formed more slowly in the presence of cholester-
ol while sphingomyelin does not seem to have a speciﬁc effect on the
kinetics of ﬁbril formation.3.4. Fibril morphology upon incubation with the different lipid systems
Finally, the amyloid ﬁbrils were examined by TEM, revealing that
the morphology of the ﬁbrils was particular to the lipid system
(Fig. 3A–P). In solution (data not shown) and for all the LUV and
SUV, the ﬁbrils exhibited the typical morphology of long and twist
amyloid ﬁbrils with widths between 10 and 15 nm. Interestingly,
the ﬁbrils seemed to propagate along the vesicle's surface and
distorted vesicles (asterisks in Fig. 3H) are present near the IAPP ﬁ-
brils (black arrows in Fig. 3H). In SDS and DPC micelles, no ﬁbrils
were found even after several days of incubation (Fig. 3E–F). These
results are consistent with our ThT ﬂuorescence and CD data that re-
spectively show no increase in ThT signal after few hours of incuba-
tion, and predominantly α-helical structure during several days of
incubation. Thus, our TEM results suggest that in SDS and DPC mi-
celles the peptide is not ﬁbrillogenic. In DHPC/DMPC bicelles, ﬁbrils
were observed after a few hours of incubation in agreement with
our CD data and ThT experiments. However, the morphology of
these ﬁbrils is different from the one in the LUV (Fig. 3G). Indeed,
the populations of IAPP ﬁbrillar assemblies in the bicelles consist of
thinner structures than in other vesicles with widths between 8 and
12 nm.
Fig. 2.Monitoring the IAPP-ﬁbril formation by ThT ﬂuorescence in the presence of (A) DOPC (dash), DOPC/DOPS 7:3 (ﬁlled circles), DOPC/DOPG 7:3 (open squares), DOPC/DOPE 7:3
(cross); (B) DMPC/DHPC bicelles (ﬁlled circles), SDS micelles (open squares), DPC (cross) micelles, DOPC 50 nm SUV (open diamonds) and DOPC 800 nm LUVs (stars); (C) DOPC
(dot), DMPC (open squares), POPC (ﬁlled circle) and DPPC (cross); (D) DOPC (dash), DOPC/Chol 7:3 (open squares), DOPC/SM 7:3 (cross), DOPC/Chol/SM 4:3:3 (ﬁlled circles) and
POPC/Chol/SM 1:1:1 (ﬁlled diamonds).
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In vitro studies on model membranes have shown that membrane
permeabilization by amyloidogenic peptides is highly dependent on
the lipid composition of the membrane [14,33]. Therefore, an under-
standing of lipid speciﬁcity of amyloid peptide–lipid interactions can
lead to a better understanding of the mechanisms of amyloid cytotox-
icity. In the present study we have investigated and compared the ag-
gregational behaviour of IAPP in lipid membrane models of different
compositions and sizes. We have made the following key observa-
tions: i) SDS and DPC micelles stabilize α-helical conformations and
no IAPP ﬁbril formation was observed in these media; ii) DMPC/
DHPC bicelles and DOPC SUV tend to accelerate IAPP ﬁbril formation;
iii) the headgroup of the lipid strongly inﬂuences the kinetics of am-
yloid formation, as revealed by ThT-ﬂuorescence; the length and theTable 2
Kinetic parameters (lag time t0.5 and elongation rate dt) of IAPP ﬁbril formation in the
different media determined using ThT-ﬂuorescence.
Membranes t1/2 (h) dt (h−1)
Lipid-free 9.7 ± 1.0 1.5 ± 0.2
DOPC 11.8 ± 1.2 2.6 ± 0.2
DOPC/DOPS 2.1 ± 0.5 0.2 ± 0.2
DOPC/DOPG 2.2 ± 0.5 0.2 ± 0.2
DOPC/DOPE (7:3) 20.2 ± 2.0 0.8 ± 0.2
DOPC 50 nm 6.3 ± 0.8 1.3 ± 0.2
DOPC 800 nm 15.5 ± 1.5 2.3 ± 0.2
DMPC 10.7 ± 1.2 2.1 ± 0.2
DPPC 12.3 ± 1.2 1.3 ± 0.2
POPC 13.6 ± 1.2 1.6 ± 0.2
DOPC/Chol (7:3) 20.1 ± 2.0 2.9 ± 0.2
DOPC/SM (7:3) 13.1 ± 1.8 1.6 ± 0.2
DOPC/Chol/SM (4:3:3) 13.1 ± 1.2 1.6 ± 0.2
POPC/Chol/SM (1:1:1) 12.9 ± 1.3 2.4 ± 0.2
Bicelles 8.5 ± 0.8 2.8 ± 0.2degree of unsaturation of the lipid chains have little effect on the ﬁbril
formation as assessed by ThT ﬂuorescence but affect peptide β-sheet
transition as observed by CD; iv) lipid rafts containing cholesterol
tend to retard IAPP ﬁbril formation. These ﬁndings are discussed
below.
The CD, TEM and ThT ﬂuorescence studies of IAPP in micelles re-
veal several interesting features. No ﬁbrils were found in these
media after several days of incubation, consistent with our ThT ﬂuo-
rescence and CD data that show no increase in ThT signal after
2 days of incubation, and predominantly α-helical structure for sev-
eral days in both anionic and zwitterionic micelles. It appears reason-
able to suggest that micelles inhibit ﬁbril formation of IAPP and may
stabilize a monomeric form or small soluble oligomeric forms of
IAPP that exhibit mainly α-helical conformations. The micelles
models are thus suitable to characterize the solution conformation
of IAPP as was done by the group of Ramamoorthy, which solved
the high-resolution structure of IAPP in SDS micelles using NMR
[34,35]. Similarly, Aβ peptide, aggregating in Alzheimer's disease
has also been studied in DPC micelles and SDS micelles [36,37]. Inter-
estingly, our experiments in small isotropic DHPC/DMPC bicelles and
SUV show that these media promote IAPP ﬁbril formation within a
few hours. These two mimetics are considered as better models
than micelles, since the composition and conditions can be varied to
better reproduce speciﬁc biological membranes [38]. Our study clear-
ly demonstrates that small isotropic bicelles and SUV are appropriate
for studying the membrane interactions of amyloidogenic peptides
such as IAPP. Small isotropic bicelles in particular are amenable to
high resolution solution NMR studies so the structure of IAPP species
bound to membranes could be determined using such mimetics.
Noteworthy, the ﬁbrils formed in the presence of small isotropic
bicelles show slightly altered morphology with thinner structures.
This may indicate that the bicelle environment provides a limited
area to accommodate IAPP oligomers on the membrane surface dur-
ing the nucleation process.
Fig. 3. Negatively stained microscopy images of IAPP after incubation of 24 h with vesicles composed of: (A) DOPC, (B) DOPC/DOPS 7:3, (C) DOPC/DOPG 7:3, (D) DOPC/DOPE 7:3,
(E) with SDS micelles, (F) DPC micelles, (G) DMPC/DHPC bicelles, (H) with DOPC SUV (50 nm), (I) DOPC 800 nm, (J) DMPC, (K) DPPC (L) POPC, (M)DOPC/Chol 7:3, (N) DOPC/SM
7:3,(O) DOPC/Chol/SM 4:3:3and (P) POPC/Chol/SM 1:1:1. All SUV and LUV incubated experiments had a 1:20 peptide to lipid molar ratio. Scale bars represent 500 nm.
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adopts an α-helical structure, in agreement with previous reports
[14,39]. A transition ofα-helical toβ-sheet structure is observed, that re-
sults inﬁbril formation. Thisα-helical toβ-sheet transition has also been
observed for many amyloidogenic proteins, such as Aβ peptide and the
N-terminal part of α-synuclein (aggregating in Parkinson's disease)
[40,41]. In addition, our results show that negatively charged lipids ac-
celerate IAPP-ﬁbril formation while they appeared to slow down
Aβ-ﬁbril formation [42]. These diverging kinetics effects can be related
to the different isoelectric points of Aβ and IAPP peptides that exhibit
negative and positive charges, respectively, at neutral pH. Our data indi-
cate that the net surface charge is an important property of the mem-
brane that strongly affects the kinetics of amyloid formation, however
no noticeable difference was observed between phosphatidylserine
and phosphatidylglycerol anionic headgroups.In the presence of the zwitterionic phosphatidylethanolamine, a dif-
ferent behaviourwas observed: the kinetics of ﬁbril formation is slower
(with a lag-time of approximately 21 h) while the α-helical to β-sheet
transition, as observed by CD, occurs faster, after few hours. It is impor-
tant to keep in mind that the ThT-ﬂuorescence was performed in the
presence of salt, which should even accelerate the kinetics of ﬁbril for-
mation,while theCDexperiments performedwithout salt should retard
the kinetics of conformational change. Thus, the diverging kinetics
followed by ThT ﬂuorescence and CD spectroscopy suggest that the
presence of phosphatidylethanolamine stabilizes some oligomeric
β-sheet-structures of IAPP but slows down IAPP-ﬁbril formation. It
was recently proposed that IAPP oligomers are prone to form on the
membrane surface and that phosphatidylethanolamine may indeed
favour the formation of oligomers by increasing the amount of
membrane-bound IAPP [43,44]. The comparison of models yields
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process. The kinetics is slowed down in the presence of PE which has
a negative curvature while SUV exhibiting a positive curvature tend to
accelerate ﬁbril formation.
The length and the degree of unsaturation of the lipid chains have
little effect on the ﬁbril formation but affect the transition from the
non-amyloidogenic conformation (random coil) of monomeric IAPP
and small soluble oligomers to the β-sheet-rich conformation. Indeed,
our results show that DPPC LUV presented the longest conformational
transition time compared to DOPC, DMPC and POPC LUV. Importantly,
at this temperature (25 °C) DPPC is in ordered (gel) lipid phase,
which induces change in the structural characteristics and dynamics
properties of the membranes. Thus, we might assume that the pep-
tide has difﬁculty to insert in the bilayer due to the ordered phase
that may retard the random coil to β-sheet transition.
The addition of sphingomyelin in the membrane models did not
show any effect on IAPP-ﬁbril morphology neither on ﬁbril formation
with similar lag-time of approximately 12 h in both systems. This was
unexpected since previous results on Aβ peptide, show a clear inter-
action between Aβ and several sphingolipids and in vivo experiments
demonstrate that sphingomyelin is critical in Aβ-amyloid ﬁbrillation
in the brain [45].
The role of cholesterol in amyloid disease development is unclear, as
the literature data show contradictory results indicating either that cho-
lesterol has a protective effect against membrane permeabilization or
that cholesterol is impairing the membrane stability [46–49]. The
exact role of cholesterol in IAPP ﬁbril formation andmembrane damage
is currently in question. Our CD and ThT-ﬂuorescence results show that
the vesicles containing 30% of cholesterol (i.e., DOPC/Chol 7:3) slow
down the kinetics of oligomer formation as well as of IAPP-ﬁbril forma-
tion. The cholesterol effects could be due to themodulation of the phys-
ical properties of the membrane and/or due to direct interactions with
IAPP within the membrane core. Indeed, cholesterol is a known regula-
tor of membrane ﬂuidity. It is therefore quite possible that cholesterol,
bymodulatingmembrane ﬂuidity and/ormembrane curvature, also in-
ﬂuences IAPP–lipid interaction and reduces IAPP-ﬁbril formation.
In conclusion, our data indicate that the lipid composition of ves-
icles has a large effect on IAPP-ﬁbril formation by accelerating or
slowing down the kinetics, but has only slight effects on the morphol-
ogy of ﬁnal amyloid ﬁbrils, as observed by EM. It is important to note
that the ﬁbrils morphology is the same in the absence and in the pres-
ence of lipid vesicles. Membrane models also affect the kinetics of
β-sheet conformational transition and of amyloid ﬁbril formation to
different extents. It is therefore likely that the modulation of lipid
composition inﬂuences not only the interactions of β-sheet oligomers
with membranes but also the growth of ﬁbrils at the membrane sur-
face. Thus, the discrepancy of results found in the literature is most
likely due to variation of lipid compositions and membrane models
used by the authors.Acknowledgements
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